Genelux (GNLX) closed at $1.95 on November 10, 2026, down 5.8% from the previous close, on volume of 92,373 shares (30-day average 380,960).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
Globe Newswire (Wed, 9-Sep 4:01 PM ET)
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
Globe Newswire (Thu, 13-Aug 4:20 PM ET)
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Genelux trades on the NASDAQ stock market under the symbol GNLX.
As of November 11, 2026, GNLX stock price climbed to $1.99 with 1,917 million shares trading.
GNLX has a beta of 1.34, meaning it tends to be more sensitive to market movements. GNLX has a correlation of 0.04 to the broad based SPY ETF.
GNLX has a market cap of $90.04 million. This is considered a Micro Cap stock.
In the last 3 years, GNLX traded as high as $16.60 and as low as $1.60.
The top ETF exchange traded funds that GNLX belongs to (by Net Assets): VTI, VXF, IWC.
GNLX has underperformed the market in the last year with a price return of -66.2% while the SPY ETF gained +12.1%. GNLX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.8% and -2.9%, respectively, while the SPY returned -1.9% and -1.8%, respectively.
GNLX support price is $1.82 and resistance is $2.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNLX shares will trade within this expected range on the day.
